ArticleTrials2025

Efficacy and safety of levothyroxine monotherapy in lowering the risk of cardiovascular disease in older adults with subclinical hypothyroidism: research protocols of a multicenter, open-label, randomized controlled trial.

Chong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.